Impact of industry collaboration on randomised controlled trials in oncology

详细信息    查看全文

• 作者：Anne Linker^a ; ^{Anne.linker@ucsf.edu} ; Annie Yang^b ; ^{yanga1@mskcc.org} ; Nitin Roper^c ; ^{Nitin.roper@nih.gov} ; Evans Whitaker^d ; ^{Evans.whitaker@ucsf.edu} ; Deborah Korenstein^e ; ^{korenstd@mskcc.org}
• 关键词：Conflict of interest ; Disclosure ; Drug industry ; Collaboration ; Randomised controlled trials
• 刊名：European Journal of Cancer
• 出版年：2017
• 出版时间：February 2017
• 年：2017
• 卷：72
• 期：Complete
• 页码：71-77
• 全文大小：289 K
• 卷排序：72

文摘

Industry may collaborate in trial design and execution or simply provide funds. Trials with industry collaboration differ from those without industry funding. Industry collaboration is associated with placebo control and more blinding. Industry collaboration is not associated with higher rate of positive results. Trials with industry funding only are similar to those without funding.